Drugs.com - Pharma Industry News

Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer

THURSDAY, April 17, 2025 -- Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially vulnerable populations are less likely to achieve quality indicators associated with survival...

Apr 17, 2025 - 18:59
 0
Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer
THURSDAY, April 17, 2025 -- Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially vulnerable populations are less likely to achieve quality indicators associated with survival...
Read More

Tags:

Previous Article

Early Pregnancy BP Trajectories Linked to New-Onset HTN Years Later

Next Article

Yoga May Aid Knee Osteoarthritis Pain

Related Posts

1990 to 2021 Saw Increase in Global Burden of Diabetic Nephropathy

1990 to 2021 Saw Increase in Global Burden of Diabetic ...

Mar 17, 2025  0

Risk for Rehospitalization Higher for Patients With Takotsubo Syndrome

Risk for Rehospitalization Higher for Patients With Tak...

Mar 28, 2025  0

Common Photosensitizing Drugs Increase Skin Cancer Risk

Common Photosensitizing Drugs Increase Skin Cancer Risk

Apr 2, 2025  0